Thu, 29th Sep 2016 11:55
LONDON (Alliance News) - Allergy vaccines developer Allergy Therapeutics PLC said Thursday Chairman Peter Jensen bought 30,000 shares at a price of 19.25 pence per share on Wednesday.
Jensen now holds 150,000 shares.
The stock was up 2.3% at 19.70p Thursday.
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun
Copyright 2016 Alliance News Limited. All Rights Reserved.
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately repor...
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.
(Alliance News) - Allergy Therapeutics PLC on Tuesday said it has commenced subcutaneous dosing of peanut allergic patients in its phase 1/2a Protect ...
Allergy Thera. (AGY)